Comparison of risankizumab with apremilast for the treatment of moderate psoriasis. . Br J Dermatol 2023;189:e91.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Comparison of risankizumab with apremilast for the treatment of moderate psoriasis. Br J Dermatol 2023;189:e91.
PMID: 37879737